Search research articles
Contact Us
Filters
Showing results (81-90 of 531) with videos related to
Page
of 54
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model
D M Cappelletty, M J Rybak
Pharmacotherapy
|
March 16, 2005
Community-associated methicillin-resistant Staphylococcus aureus: a review
Michael J Rybak, Kerry L LaPlante
Diagnostic Microbiology and Infectious Disease
|
October 12, 2004
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline
Kerry L LaPlante, Michael J Rybak
Expert Opinion on Emerging Drugs
|
July 2, 2005
Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria
G W Kaatz, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
September 1, 1982
Antimicrobial susceptibility tests
S A Hunt, M J Rybak
Clinical Pharmacy
|
November 1, 1984
Antihypertensive agents and hyperlipidemia
L M Gutschi, M J Rybak
Pharmacotherapy
|
March 26, 2010
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens
Molly E Steed, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
May 18, 2011
Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic model
Molly Steed, Celine Vidaillac, Michael J Rybak
Wiadomosci Parazytologiczne
|
August 4, 2006
Glossiphoniidae Vaillant, 1850 (Hirudinea) of Poland--systematics and perspectives of studies
A Bielecki, J Rybak, M Lukowiak-Bielecka
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 22, 2022
Reply to Scheetz et al
Sara Alosaimy, Michael J Rybak, George Sakoulas
Page
of 54
Search research articles
Search
Showing results (81-90 of 531) with videos related to
Sort By:
Page
of 54
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model
D M Cappelletty, M J Rybak
Pharmacotherapy
|
March 16, 2005
Community-associated methicillin-resistant Staphylococcus aureus: a review
Michael J Rybak, Kerry L LaPlante
Diagnostic Microbiology and Infectious Disease
|
October 12, 2004
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline
Kerry L LaPlante, Michael J Rybak
Expert Opinion on Emerging Drugs
|
July 2, 2005
Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria
G W Kaatz, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
September 1, 1982
Antimicrobial susceptibility tests
S A Hunt, M J Rybak
Clinical Pharmacy
|
November 1, 1984
Antihypertensive agents and hyperlipidemia
L M Gutschi, M J Rybak
Pharmacotherapy
|
March 26, 2010
Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens
Molly E Steed, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
May 18, 2011
Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic model
Molly Steed, Celine Vidaillac, Michael J Rybak
Wiadomosci Parazytologiczne
|
August 4, 2006
Glossiphoniidae Vaillant, 1850 (Hirudinea) of Poland--systematics and perspectives of studies
A Bielecki, J Rybak, M Lukowiak-Bielecka
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 22, 2022
Reply to Scheetz et al
Sara Alosaimy, Michael J Rybak, George Sakoulas
Page
of 54